HR
Healthcare Realty Trust Incorporated
$20.36
+0.00
(+0.00%)
Mkt Cap
7.14B
Volume
2,162,322
52W Range
14.09-20.6
Sector
Real Estate
Beta
0.82
EPS (TTM)
-0.58
P/E Ratio
-24.09
Revenue (TTM)
1.16B
Rev Growth (5Y)
+9.9%
EPS Growth (5Y)
N/A
AlphaVal · Fair Value
$19.56
Overvalued · Mild
4.1% above fair value
AlphaQuality · Grade · Gated
F
Real Estate Investment Trust
30.0 / 100 pillar composite (overridden)
Company Description
Healthcare Realty Trust is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of September 30, 2020, the Company owned 211 real estate properties in 24 states totaling 15.5 million square feet and was valued at approximately $5.5 billion. The Company provided leasing and property management services to 11.9 million square feet nationwide.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.18B | 1.27B | 1.34B | 932.64M | 534.82M | 735.07M | 693.63M | 695.30M | 613.11M | 460.48M | 403.41M | 371.05M |
| Net Income | (246.07M) | (654.49M) | (278.26M) | 40.90M | 66.66M | 52.62M | 30.15M | 213.46M | 63.92M | 49.95M | 32.93M | 45.37M |
| EPS | -0.71 | -1.81 | -0.74 | 0.15 | 0.45 | 0.24 | 0.15 | 1.04 | 0.35 | 0.34 | 0.26 | 0.38 |
| Free Cash Flow | 126.94M | 252.64M | 268.79M | 109.20M | 131.94M | 376.13M | 148.47M | 137.55M | 99.15M | 79.84M | N/A | N/A |
| FCF / Share | 0.36 | 0.69 | 0.71 | 0.43 | 0.93 | 1.72 | 0.72 | 0.67 | 0.55 | 0.58 | N/A | N/A |
| Operating CF | 457.10M | 501.62M | 499.82M | 272.75M | 232.63M | 470.09M | 213.14M | 208.35M | 179.77M | 151.27M | N/A | N/A |
| Total Assets | 9.21B | 10.65B | 12.64B | 13.85B | 4.26B | 3.81B | 3.56B | 3.19B | 3.19B | 3.04B | N/A | N/A |
| Total Debt | 4.15B | 4.96B | 5.30B | 5.70B | 1.92B | 1.71B | 1.52B | 1.35B | 1.28B | 1.26B | N/A | N/A |
| Cash & Equiv | 26.17M | 68.92M | 25.70M | 60.96M | 13.18M | 15.30M | 657,000 | 8.38M | 6.21M | 5.41M | N/A | N/A |
| Book Value | 4.62B | 5.23B | 6.82B | 7.57B | 2.19B | 1.95B | 1.90B | 1.72B | 1.79B | 1.65B | N/A | N/A |
| Return on Equity | -0.05 | -0.13 | -0.04 | 0.01 | 0.03 | 0.03 | 0.02 | 0.12 | 0.04 | 0.03 | N/A | N/A |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 278.99M | 286.30M | 297.76M | 297.50M | 298.98M | 309.77M | 315.42M | 316.32M | 326.81M | 330.44M | 342.26M | 338.14M |
| Net Income | (56,000) | 14.39M | (57.74M) | (157.85M) | (44.87M) | (106.85M) | (93.02M) | (143.78M) | (310.84M) | (40.53M) | (67.84M) | (82.76M) |
| EPS | -0.00 | 0.04 | -0.17 | -0.45 | -0.13 | -0.31 | -0.26 | -0.39 | -0.82 | -0.11 | -0.18 | -0.22 |
| Free Cash Flow | (8.28M) | 45.79M | 24.93M | 77.56M | (21.34M) | 75.77M | 50.33M | 100.77M | 25.76M | 53.16M | 55.32M | 151.28M |
| FCF / Share | -0.02 | 0.13 | 0.07 | 0.22 | -0.06 | 0.22 | 0.14 | 0.27 | 0.07 | 0.14 | 0.15 | 0.40 |
| Operating CF | 52.88M | 132.34M | 113.75M | 163.22M | 47.79M | 138.01M | 119.30M | 168.15M | 76.15M | 127.32M | 118.18M | 185.13M |
| Total Assets | 9.15B | 9.21B | 9.86B | 10.24B | 10.50B | 10.65B | 11.24B | 11.80B | 12.28B | 12.64B | 13.10B | 13.39B |
| Total Debt | 4.34B | 4.15B | 4.72B | 4.97B | 5.03B | 4.96B | 5.26B | 5.45B | 5.41B | 5.30B | 5.57B | 5.69B |
| Cash & Equiv | 26.23M | 26.17M | 43.34M | 25.51M | 25.72M | 68.92M | 22.80M | 41.77M | 26.17M | 25.70M | 24.67M | 35.90M |
| Book Value | 4.44B | 4.62B | 4.68B | 4.82B | 5.08B | 5.23B | 5.52B | 5.89B | 6.42B | 6.82B | 7.00B | 7.18B |
| Return on Equity | -0.00 | 0.00 | -0.01 | -0.03 | -0.01 | -0.02 | -0.02 | -0.02 | -0.05 | -0.01 | -0.01 | -0.01 |
HR News
Healthcare Realty Trust: Betting On Outpatient Demand Growth, Lower Operator Risk (Upgrade)
ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US for two new indications for patients with HER2-positive early breast cancer
H&R Real Estate Investment Trust (HR.UN:CA) Q1 2026 Earnings Call Transcript
D2L Survey Reveals How AI is Beginning to Reshape Entry-Level Work and the Talent Pipeline
Healthcare Realty Announces Pricing of Upsized $600 Million Exchangeable Senior Notes Offering
Healthcare Realty Announces Proposed Exchangeable Senior Notes Offering
REITs Excel, Earnings Swell, Fed Rebels
Healthcare Realty Trust Incorporated (HR) Q1 2026 Earnings Call Transcript
Healthcare Realty Reports First Quarter 2026 Results and Increases Full Year 2026 Guidance
A Fragile Truce